Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).

Source:http://linkedlifedata.com/resource/pubmed/id/12374696

Download in:

View as

General Info

PMID
12374696